Table 1 Study procedures
Procedure | Baseline | Days 1 – 7 | Days 8–13 | Day 14 | Day 30 (end of study) |
|---|---|---|---|---|---|
Clinical evaluation | √ | √ |  | √ | √ |
Informed consent | √ |  |  |  |  |
Randomisation | √ |  |  |  |  |
ECG | √ | √ |  | √ |  |
Study drug given |  | √ | √ | √ |  |
Full blood count | √ | √ |  | √ |  |
Creatinine, electrolytes, eGFR | √ | √ |  | √ |  |
Troponin | √ | √ |  | √ |  |
hsCRP | √ | √ |  | √ | √ |
Liver function tests | √ |  |  | √ |  |
IL-6, vWF | √ | √ |  | √ | √ |
Post discharge follow up visit |  |  |  | √ | √ |
Samples for DNA & RNA | √ |  |  |  | √ |
Cardiac magnetic resonance scan (1) |  | √ |  |  | √ |
ST segment monitoring (2) |  | √ |  |  |  |
Forearm endothelial study (3) |  | √ |  | √ |  |